- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- NAG- MAN: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.2: 5 residues within 4Å:- Chain A: N.157, T.159
- Chain C: S.211, P.213, W.214
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: A:T.159
- Hydrogen bonds: C:W.214
NAG-NAG-BMA-MAN-MAN.16: 5 residues within 4Å:- Chain C: N.157, T.159
- Chain E: S.211, P.213, W.214
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain E- Hydrophobic interactions: C:T.159
- Hydrogen bonds: E:W.214
NAG-NAG-BMA-MAN-MAN.30: 5 residues within 4Å:- Chain A: S.211, P.213, W.214
- Chain E: N.157, T.159
2 PLIP interactions:1 interactions with chain E, 1 interactions with chain A- Hydrophobic interactions: E:T.159
- Hydrogen bonds: A:W.214
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.3: 5 residues within 4Å:- Chain A: S.37, N.277, V.289, N.290
- Chain B: E.69
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.17: 5 residues within 4Å:- Chain C: S.37, N.277, V.289, N.290
- Chain D: E.69
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.31: 5 residues within 4Å:- Chain E: S.37, N.277, V.289, N.290
- Chain F: E.69
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.4: 3 residues within 4Å:- Chain B: A.147, E.150, N.154
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 3 residues within 4Å:- Chain D: A.147, E.150, N.154
No protein-ligand interaction detected (PLIP)NAG-NAG.32: 3 residues within 4Å:- Chain F: A.147, E.150, N.154
No protein-ligand interaction detected (PLIP)- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 3 residues within 4Å:- Chain A: N.14, T.16, T.29
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:T.16
- Hydrogen bonds: A:N.14
NAG.6: 3 residues within 4Å:- Chain A: Q.72, N.73, F.112
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:Q.72
- Hydrogen bonds: A:Q.72, A:N.73
- Water bridges: A:T.114
NAG.19: 3 residues within 4Å:- Chain C: N.14, T.16, T.29
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:T.16
- Hydrogen bonds: C:N.14
NAG.20: 3 residues within 4Å:- Chain C: Q.72, N.73, F.112
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:Q.72
- Hydrogen bonds: C:Q.72, C:N.73
- Water bridges: C:T.114
NAG.33: 3 residues within 4Å:- Chain E: N.14, T.16, T.29
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:T.16
- Hydrogen bonds: E:N.14
NAG.34: 3 residues within 4Å:- Chain E: Q.72, N.73, F.112
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:Q.72
- Hydrogen bonds: E:Q.72, E:N.73
- Water bridges: E:T.114
- 21 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.7: 7 residues within 4Å:- Chain A: M.260, R.261, I.292
- Chain B: E.67, K.68, E.69
- Ligands: PEG.8
Ligand excluded by PLIPPEG.8: 10 residues within 4Å:- Chain A: I.259, M.260, K.291, I.292, T.293
- Chain B: Q.65, I.66, E.67, K.68
- Ligands: PEG.7
Ligand excluded by PLIPPEG.9: 7 residues within 4Å:- Chain B: E.69, F.70, E.72, V.73, Q.78, K.82
- Ligands: PEG.12
Ligand excluded by PLIPPEG.10: 9 residues within 4Å:- Chain A: K.291
- Chain B: I.66, E.67, K.68, F.70, E.81, K.82, E.85, D.86
Ligand excluded by PLIPPEG.11: 7 residues within 4Å:- Chain B: D.79, K.82, Y.83, D.86
- Chain F: H.64, Q.65
- Ligands: PEG.12
Ligand excluded by PLIPPEG.12: 8 residues within 4Å:- Chain B: V.73, E.74, G.75, Q.78, D.79, K.82
- Ligands: PEG.9, PEG.11
Ligand excluded by PLIPPEG.13: 3 residues within 4Å:- Chain A: K.299
- Chain B: R.54, V.55
Ligand excluded by PLIPPEG.21: 7 residues within 4Å:- Chain C: M.260, R.261, I.292
- Chain D: E.67, K.68, E.69
- Ligands: PEG.22
Ligand excluded by PLIPPEG.22: 10 residues within 4Å:- Chain C: I.259, M.260, K.291, I.292, T.293
- Chain D: Q.65, I.66, E.67, K.68
- Ligands: PEG.21
Ligand excluded by PLIPPEG.23: 7 residues within 4Å:- Chain D: E.69, F.70, E.72, V.73, Q.78, K.82
- Ligands: PEG.26
Ligand excluded by PLIPPEG.24: 9 residues within 4Å:- Chain C: K.291
- Chain D: I.66, E.67, K.68, F.70, E.81, K.82, E.85, D.86
Ligand excluded by PLIPPEG.25: 7 residues within 4Å:- Chain B: H.64, Q.65
- Chain D: D.79, K.82, Y.83, D.86
- Ligands: PEG.26
Ligand excluded by PLIPPEG.26: 8 residues within 4Å:- Chain D: V.73, E.74, G.75, Q.78, D.79, K.82
- Ligands: PEG.23, PEG.25
Ligand excluded by PLIPPEG.27: 3 residues within 4Å:- Chain C: K.299
- Chain D: R.54, V.55
Ligand excluded by PLIPPEG.35: 7 residues within 4Å:- Chain E: M.260, R.261, I.292
- Chain F: E.67, K.68, E.69
- Ligands: PEG.36
Ligand excluded by PLIPPEG.36: 10 residues within 4Å:- Chain E: I.259, M.260, K.291, I.292, T.293
- Chain F: Q.65, I.66, E.67, K.68
- Ligands: PEG.35
Ligand excluded by PLIPPEG.37: 7 residues within 4Å:- Chain F: E.69, F.70, E.72, V.73, Q.78, K.82
- Ligands: PEG.40
Ligand excluded by PLIPPEG.38: 9 residues within 4Å:- Chain E: K.291
- Chain F: I.66, E.67, K.68, F.70, E.81, K.82, E.85, D.86
Ligand excluded by PLIPPEG.39: 7 residues within 4Å:- Chain D: H.64, Q.65
- Chain F: D.79, K.82, Y.83, D.86
- Ligands: PEG.40
Ligand excluded by PLIPPEG.40: 8 residues within 4Å:- Chain F: V.73, E.74, G.75, Q.78, D.79, K.82
- Ligands: PEG.37, PEG.39
Ligand excluded by PLIPPEG.41: 3 residues within 4Å:- Chain E: K.299
- Chain F: R.54, V.55
Ligand excluded by PLIP- 3 x PE5: 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL(Non-covalent)
PE5.14: 16 residues within 4Å:- Chain A: Y.97, A.98, R.101, S.102, R.261
- Chain B: H.64, Q.65, I.66, E.67, F.70, S.71, E.72, E.74, E.81
- Chain D: R.76, D.79
12 PLIP interactions:3 interactions with chain A, 9 interactions with chain B- Hydrogen bonds: A:R.101, A:S.102, A:R.261, B:E.67, B:E.67, B:S.71, B:S.71, B:E.72, B:E.72, B:E.74
- Water bridges: B:S.71, B:E.74
PE5.28: 16 residues within 4Å:- Chain C: Y.97, A.98, R.101, S.102, R.261
- Chain D: H.64, Q.65, I.66, E.67, F.70, S.71, E.72, E.74, E.81
- Chain F: R.76, D.79
10 PLIP interactions:3 interactions with chain C, 7 interactions with chain D- Hydrogen bonds: C:R.101, C:S.102, C:R.261, D:E.67, D:S.71, D:S.71, D:E.72, D:E.74
- Water bridges: D:S.71, D:E.74
PE5.42: 16 residues within 4Å:- Chain B: R.76, D.79
- Chain E: Y.97, A.98, R.101, S.102, R.261
- Chain F: H.64, Q.65, I.66, E.67, F.70, S.71, E.72, E.74, E.81
11 PLIP interactions:8 interactions with chain F, 3 interactions with chain E- Hydrogen bonds: F:E.67, F:S.71, F:S.71, F:E.72, F:E.72, F:E.74, E:R.101, E:S.102, E:R.261
- Water bridges: F:S.71, F:E.74
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, H. et al., Structure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutinins. Virology (2015)
- Release Date
- 2015-02-11
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- NAG- MAN: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 21 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 3 x PE5: 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, H. et al., Structure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutinins. Virology (2015)
- Release Date
- 2015-02-11
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B